Australia Blood Glucose Monitoring Market Size, Share, and COVID-19 Impact Analysis, By Type (Self-monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices), By Component (Glucometer Devices, Lancets, Test Strips, Durables, and Sensors), and Australia Blood Glucose Monitoring Market Insights, Industry Trend, Forecasts to 2033

Australia Blood Glucose Monitoring Market Insights Forecasts to 2033

• The Australia Blood Glucose Monitoring Market Size Was Estimated at USD 278.30 Million in 2023.
• The Market Size is Growing at a CAGR of 8.56% from 2023 to 2033
• The Australia Blood Glucose Monitoring Market Size is Expected to Reach USD 632.54 Million by 2033

The Australia Blood Glucose Monitoring Market Size is Expected to reach USD 632.54 Million by 2033, Growing at a CAGR of 8.56% from 2023 to 2033.

Market Overview

The Australia blood glucose monitoring market covers both continuous and self-monitoring glucose monitoring systems, as well as the manufacturing, distribution, and usage of technologies and equipment that measure blood glucose levels, mainly for the treatment of diabetes. The market is primarily affected by the rising incidence of diabetes and the aging population, who are particularly susceptible to diseases like diabetes.  In addition, the demand for blood glucose monitoring devices has increased as a result of a greater awareness among Australians on the significance of diabetes care and routine monitoring. Campaigns for education and public health programs can raise awareness of this issue.  Patient empowerment and self-monitoring are becoming more and more popular in the medical field. Additionally, new product introductions and increased awareness of diabetes prevention strategies are driving market expansion. Furthermore, the government initiatives aid in the expansion of the market such as, support services and blood glucose monitoring equipment receive funding by the National Diabetes Services Scheme (NDSS).

Report Coverage

This research report categorizes the market for the Australia blood glucose monitoring market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Australia blood glucose monitoring market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Australia blood glucose monitoring market.

Driving Factors

The Australia blood glucose monitoring market is growing due to one of the main factors driving the need for blood glucose monitoring devices in Australia is the high and rising prevalence of diabetes. Effective monitoring systems are essential for managing diabetes, as the number of people with the diagnosis rises. Additionally, the stability of Australia's economy contributes to keeping medical services and equipment affordable.  Blood glucose monitoring devices are accessible to people with diabetes, guaranteeing their widespread adoption and use.

Restraining Factors

Australia's blood glucose monitoring market expansion is anticipated to be impeded by regulatory complexity, low awareness in remote regions, and the expensive cost of continuous glucose monitoring (CGM) devices are some of the obstacles facing the Australian blood glucose monitoring market that may prevent widespread acceptance and market expansion.

Market Segmentation

The Australian blood glucose monitoring market share is classified into type and component.

• The continuous glucose monitoring devices segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR during the forecast period.

Based on the type, the Australian blood glucose monitoring market is categorized into self-monitoring blood glucose devices and continuous glucose monitoring devices. Among these, the continuous glucose monitoring devices segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR during the forecast period. Blood sugar levels are measured by glucose oxidase in continuous glucose monitoring systems.  The goals of technological developments are to improve sensor accuracy and produce more reasonably priced, approachable gadgets. In addition, compared to electrochemical sensors, the fluorescence-detecting CGM sensor Eversense has a longer lifespan.

• The glucometer devices segment accounted for a significant market share in 2023 and is expected to grow at a significant CAGR during the forecast period.

Based on the component, the Australia blood glucose monitoring market is classified into glucometer devices, lancets, test strips, durables, and sensors. Among these, the glucometer devices segment accounted for a significant market share in 2023 and is expected to grow at a significant CAGR during the forecast period. This segment is growing because of increased usage as a result of the incidence of diabetes and their extensive use for self-monitoring blood glucose levels.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Australia blood glucose monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Diabetes Care Inc.
• Dexcom Inc.
• Medtronic PLC
• Ascensia Diabetes Care
• Agamatrix Inc.
• Bionime Corporation
• Everesense
• Roche
• Johnson & Johnson
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In March 2025, Dexcom unveiled the Dexcom ONE+ CGM system, which is intended for those with Type 2 diabetes and offers real-time glucose monitoring without the need for finger pricks.

Market Segment

This study forecasts revenue at Australia, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Australia blood glucose monitoring market based on the below-mentioned segments:

Australia Blood Glucose Monitoring Market, By Type

• Self-monitoring Blood Glucose Devices
• Continuous Glucose Monitoring Devices

Australia Blood Glucose Monitoring Market, By Component

• Glucometer Devices
• Lancets
• Test Strips
• Durables
• Sensors